March 15 (Reuters) - Patients treated with Medtronic Plc's CoreValve non-invasive heart valve replacement system fared better two years after the procedure than those who underwent surgical valve replacement, according to data from a study presented on Sunday.
94 345,133 3 Apple AAPL 3 High Narrow 128.46 1.07 742,969 5 AIG AIG 3 High None 55.33 0.92 77,866 1 Medtronic MDT 3 Medium Wide 77.59 1.08 76,354 4 WellsFargo WFC 3 Medium Narrow 54.79 1.05 282,581 5 Allergan AGN 3 Medium
March 2 (Reuters) - A U.S. appeals court on Monday ruled that a federal jury had erred in 2011 when it awarded medical technology company Medtronic Plc $101.2 million in a patent infringement case, and ordered a new trial to determine damages.
vulnerable to new competition in DEBs. Medtronic just received FDA approval on its ..... scale launch. The clinical data on Medtronic 's product suggests even greater ..... Nonetheless, we expect the Bard and Medtronic will both see strong DEB growth
Inc., Gentiva Health Services, Inc., Invacare Corporation, F. Hoffmann-La Roche Ltd., Phillips Healthcare, Medtronic , Inc. and Omron Healthcare, Inc. The Global home healthcare market is segmented as follows: Global Home Healthcare
Feb 20 (Reuters) - The U.S. Food and Drug Administration approved Medtronic Inc's device to permanently treat varicose veins on the legs.
Feb 20 (Reuters) - The U.S. Food and Drug Administration said it approved Medtronic Inc's device to permanently treat varicose veins of the legs.
CSZ) Products Ecolab EMIT Enthermics Medical Systems GE Healthcare Geratherm Medical Healthcare 21 Inditherm Medtronic ( Medtronic acquired Covidien) Mennen Medical Group Moeck und Moeck Pintler Medical The 37Company Welkins Market Driver Increase
Feb 17 (Reuters) - Medtronic Plc plans no cuts in research and development or its sales staff as the medical device maker begins the process of integrating its $49.9 billion acquisition of Covidien...
CHICAGO Feb 17 (Reuters) - Medical device maker Medtronic Plc said on Tuesday it planned to seek approval from U.S. regulators to begin a new study of its version of a hypertension treatment in which...